EarningsQ4 2023 Earnings Report

Innate Pharma SA (IPHYF) Q4 2023 Earnings Report

27 Followers

IPHYF Q4 2023 EPS Results

Actual EPS-$0.14

Consensus EPS-$0.46

Beat/MissBeat by +$0.32

One Year Ago EPS-$0.92

Actual Revenue$18.83M

Expected Revenue$19.13M

Beat/MissMissed by -$300.30K

YoY Revenue Growth+99.27%

QuarterQ4 2023

Date03/21/2024

TimeBefore Open

Conference CallThursday, March 21, 2024

IPHYF Upcoming Earnings

Innate Pharma SA's next earnings date is estimated for March 25, 2027, based on past reporting schedules.

IPHYF Q4 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 25, 2027	2026 (Q4)	-0.28 / -	-0.353	―
Sep 17, 2026	2026 (Q2)	-0.18 / -0.24	-0.284	16.00% (+0.05)
Mar 26, 2026	2025 (Q4)	-0.14 / -0.35	-0.353	0.00% (0.00)
Sep 17, 2025	2025 (Q2)	-0.32 / -0.28	-0.353	19.35% (+0.07)
Mar 27, 2025	2024 (Q4)	-0.29 / -0.35	-0.136	-158.33% (-0.22)
Sep 12, 2024	2024 (Q2)	-0.32 / -0.35	0.023	-1650.00% (-0.38)
Mar 21, 2024	2023 (Q4)	-0.46 / -0.14	-0.921	85.19% (+0.78)
Sep 14, 2023	2023 (Q2)	0.09 / 0.02	0.091	-75.00% (-0.07)
Mar 23, 2023	2022 (Q4)	-0.44 / -0.92	-0.398	-131.43% (-0.52)
Sep 15, 2022	2022 (Q2)	0.37 / 0.09	-0.341	126.67% (+0.43)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed